安飞士巴吉集团(CAR)
icon
搜索文档
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
Prnewswire· 2024-09-18 20:30
SAN JOSE, Calif., Sept. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer Research Alliance's ("OCRA") International Gynecologic Cancer Conference taking place online September 25-27, 2024. The presentation, entitled "Autologous T Cells Engineered to Target Follicle Stimulating Hormone (FSH) Receptor in Recurrent Ovarian Cancer, A Pha ...
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
Newsfile· 2024-09-16 20:00
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MASeptember 16, 2024 8:00 AM EDT | Source: Phio Pharmaceuticals Corp.Phio's INTASYL self-delivering RNAi technology enhances cell potency and yield in Adoptive Cell Therapy Marlborough, Massachusetts--(Newsfile Corp. - September 16, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune c ...
Avis Budget Group Announces Pricing of $700 Million of Senior Notes
GlobeNewswire News Room· 2024-09-11 05:22
PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), priced a private offering of $700 million aggregate principal amount of 8.250% senior notes due 2030 (the “Notes”), which represents a $200 million increase from the previously announced size of the offering. The Notes will have a maturity date of January 15, 2030. Th ...
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Avis Rent A Car System LLC Customers Whose Data May Have Been Compromised
GlobeNewswire News Room· 2024-09-11 02:11
NEWTOWN, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Avis Rent A Car System LLC (“Avis”). Avis learned of suspicious activity on or about August 5, 2024. To join this case, go HERE. About Avis Rent a Car System LLC Avis is an American car rental company headquartered in Parsippany-Troy Hills, New Jersey. What happened? On or about August 5, 2024, Avis discovered that hackers had accessed one of their business appli ...
Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes
GlobeNewswire News Room· 2024-09-10 19:26
PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, subject to market and other customary conditions, to offer $500 million aggregate principal amount of senior notes due 2030 (the “Notes”) in a private offering. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of ...
Avis Rent A Car Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims
GlobeNewswire News Room· 2024-09-10 01:59
OKLAHOMA CITY, Okla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Murphy Law Firm is investigating claims on behalf of all individuals whose personal and confidential information was compromised in the data breach involving Avis Rent A Car (“Avis”). To join the class action lawsuit, visit our site HERE. On August 5, 2024, Avis Rent A Car System, LLC (“Avis”) detected suspicious activity on its computer network, indicating a data breach. Based on a subsequent forensic investigation, Avis determined that cybercriminal ...
Thousands of Avis car rental customers had personal data stolen in cyberattack
TechCrunch· 2024-09-09 19:40
Car rental giant Avis is notifying hundreds of thousands of people that their personal information and driver’s license numbers were stolen in an August cyberattack.The New Jersey-headquartered company said in a data breach notice filed with several U.S. attorneys general over the past week that it discovered intruders in one of its business applications on August 5 and took efforts to end the unauthorized access, which the company said began two days earlier.  Avis did not disclose the nature of the cyber ...
Canadian Apartment Properties: Crowd Comes Around To Our View
Seeking Alpha· 2024-09-06 01:32
Kaan Uluer/iStock via Getty Images Note: All amounts discussed are in Canadian Dollars. Stock Prices refer to those on the TSX and not the OTC symbol. In May of this year, we switched to a Buy on Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN:CA) (“CAPREIT”) and acquired a chunk of shares. The REIT was hit with the same malaise that infected the entire Canadian sector. But unlike some distressed names, this one had no real issues, apart from a lack of investor patience. That pat ...
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
Prnewswire· 2024-09-03 20:30
SAN JOSE, Calif., Sept. 3, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the inventor of its ovarian cancer CAR-T technology, Jose R. Conejo-Garcia, M.D., Ph.D., Professor of Immunology in the Department of Integrative Immunobiology at the Duke University School of Medicine, will be speaking at the Rivkin Center and American Association for Cancer Research (AACR) 15th Bie ...
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
GlobeNewswire News Room· 2024-09-03 19:00
Descartes-15 observed to achieve an approximately ten-fold increase relative to Descartes-08 in CAR expression and selective target-specific killing in preclinical studies GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the first patient has been dosed in its first-in-human Phase 1 trial of Descartes-15, the Company’s next-genera ...